In the tumour microenvironment, tumour-associated factors such as VEGF, TGFβ, IL-6, and PD-1 impair myeloid cell functions, resulting in inhibition of the anti-tumour immune response, which further promotes tumour growth [84,85]. The gene discussed is IL6; the disease is neoplasm.